Valuation: Dr. Reddy's Laboratories Limited

Market Cap 999B 10.47B 9.07B 8.5B 7.75B 14.58B 14.8B 99.97B 39.08B 500B 39.31B 38.46B 1,667B P/E 2027 *
26.5x
P/E 2028 * 20.6x
Enterprise Value 967B 10.14B 8.79B 8.23B 7.51B 14.11B 14.33B 96.81B 37.84B 484B 38.07B 37.24B 1,615B EV / Sales 2027 *
2.75x
EV / Sales 2028 * 2.41x
Free-Float
70.08%
Yield 2027 *
0.64%
Yield 2028 * 0.7%
1 day-0.50%
1 week+3.30%
Current month+4.47%
1 month-3.74%
3 months-6.31%
6 months-5.62%
Current year-5.67%
1 week 1,155.2
Extreme 1155.2
1,206.75
1 month 1,080.05
Extreme 1080.05
1,255.85
Current year 1,080.05
Extreme 1080.05
1,414.4
1 year 1,080.05
Extreme 1080.05
1,414.4
3 years 1,025.9
Extreme 1025.9
1,420.2
5 years 731
Extreme 731
1,420.2
10 years 377.6
Extreme 377.6
1,420.2
Manager TitleAgeSince
Chief Executive Officer 59 01/07/2019
Director of Finance/CFO - 01/08/2024
Chief Operating Officer - -
Director TitleAgeSince
Chairman 58 13/05/2014
Chairman 65 02/04/2013
Director/Board Member 65 25/10/2018
Date Insider Type Main position Quantity % Market Cap.
18/12/25 Other

Chairman

85,738,125 10.2732%
18/12/25 Other

Director

12,717,090 1.5238%
18/12/25 Other

Director

27,618,385 3.3092%
Change 5-day change 1-year change 3-year change Capi.($)
-0.50%+3.30%-1.66%+3.09% 10.52B
+0.62%+4.31%+90.83%+126.81% 1,083B
+0.46%+1.28%+51.00%+50.42% 626B
-0.58%+0.97%+25.15%+63.26% 442B
-0.92%+0.22%+48.34%+38.00% 363B
-1.32%-0.21%+29.07%+36.60% 295B
-1.20%-2.78%+5.56%+5.29% 248B
+0.71%+2.30%+46.39%+59.86% 224B
-2.51%+1.77%-6.55%-51.64% 210B
+0.16%+3.01%+13.08%+69.97% 168B
Average -0.57%+2.97%+30.12%+40.17% 366.96B
Weighted average by Cap. -0.24%+4.29%+49.08%+64.63%

Financials

2027 *2028 *
Net sales 352B 3.69B 3.2B 3B 2.73B 5.14B 5.21B 35.23B 13.77B 176B 13.85B 13.55B 588B 393B 4.12B 3.57B 3.34B 3.05B 5.73B 5.82B 39.32B 15.37B 197B 15.46B 15.13B 656B
Net income 37.22B 390M 338M 317M 289M 543M 552M 3.73B 1.46B 18.64B 1.47B 1.43B 62.14B 48.99B 514M 445M 417M 380M 715M 726M 4.9B 1.92B 24.53B 1.93B 1.89B 81.79B
Net Debt -31.58B -331M -287M -269M -245M -461M -468M -3.16B -1.24B -15.81B -1.24B -1.22B -52.73B -51.62B -541M -469M -439M -401M -753M -765M -5.17B -2.02B -25.85B -2.03B -1.99B -86.18B
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
27,527
Date Price Change Volume
12/08/26 INR 1,198.95 -0.50% 95,446
11/08/26 INR 1,205.00 +4.12% 127,265
10/08/26 INR 1,157.35 -1.25% 277,667
07/08/26 INR 1,172.00 -0.26% 65,188
06/08/26 INR 1,175.00 +0.09% 35,929
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
39
Last Close Price
1,198.95INR
Average target price
1,265.77INR
Spread / Average Target
+5.57%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DRREDDY Stock